To study the effect of panchlavan siddha ghritpan in Allergic rhinitis

A controlled phase 2 clinical study to evaluate the efficacy of panchalavan siddha ghrit orally in Vataj pratishyay with special reference to Allergic rhinitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028224

Enrollment

Registered

2020-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: Panchlavan siddha ghrit: 30ml once a day for 7 days Control Intervention1: Tab citrizine: 10mg once a day for 7 days

Eligibility

Inclusion criteria

Inclusion criteria: patients With sign and symptoms of Allergic Rhinitis like jalvatnasastrav kshavathu Anaddhapihitanasa Shirashool swarbhed

Exclusion criteria

Exclusion criteria: Patient with major illness like uncontrolled hypertension and diabetes mellitus tuberculosis and malignancy cardiac diseases etc Pregnant women and lactating women Severe obstruction of nasal cavity that is severe DNS Adhesions Nasal polyps in the nasal cavity

Design outcomes

Primary

Measure	Time frame
Reduction of sneezingTimepoint: in 7 days	—

Secondary

Measure	Time frame
Reduction of rhinorrhoeaTimepoint: 7 Days	—

Countries

India

Contacts

Public ContactDr Rajan B kulkarni

Ayurved Seva Sangh Arogyashala Rugnalaya Nashik

vaidyarajankulkarni@gmail.com9579523658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026